Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | Note 10 — Stock Incentives In April 2014, the Orchids Paper Products Company 2014 Stock Incentive Plan (the “2014 Plan”) was approved. The 2014 Plan replaced the Orchids Paper Products Company 2005 Stock Incentive Plan (the “2005 Plan”) and provides for the granting of stock options and other stock based awards to employees and Board members selected by the Board’s Compensation Committee. A total of 400,000 shares may be issued pursuant to the 2014 Plan. As of June 30, 2015, there were 315,000 shares available for issuance under the 2014 Plan. Stock Options with Time-Based Vesting Conditions The grant date fair value of the following option grants was estimated using the Black-Scholes option valuation model. Option valuation models require the input of highly subjective assumptions including the expected stock price volatility. The following table details the options granted to certain members of the Board of Directors and management that were valued using the Black-Scholes valuation model and the assumptions used in the valuation model for those grants during the six months ended June 30, 2015 and 2014: Grant Number Exercise Grant Date Risk-Free Estimated Dividend Expected Date of Shares Price Fair Value Interest Rate Volatility Yield Life (years) May-14 35,000 $ 29.65 $ 7.50 2.62 % 41 % 4.72 % 5 June-14 5,000 $ 30.09 $ 7.67 2.63 % 41 % 4.65 % 5 May-15 40,000 $ 22.485 $ 4.64 2.13 % 40 % 6.23 % 5 The Company expenses the cost of these options granted over the vesting period of the option based on the grant-date fair value of the award. Stock Options with Market-Based Vesting Conditions During the first six months of 2014, the Board of Directors granted options to purchase 145,000 shares of the Company’s common stock to certain members of management. These options will become exercisable in four equal tranches, if at all, if and when the share price of the common stock closes at a certain percentage of the purchase price of the option for three consecutive business days, in accordance with the following vesting schedule: Share price required to achieve vesting Tranche 1 $ 34.788 Tranche 2 $ 42.350 Tranche 3 $ 51.425 Tranche 4 $ 60.500 Any unvested portion of the options shall expire five years from the date of grant and the options shall terminate ten years after the date of grant. As these options include a market condition, the grant date fair value and implicit service period of these option grants were estimated using a Monte Carlo option valuation model. The following table details the options granted to certain members of management that were valued using the Monte Carlo valuation model and the assumptions used in the valuation model for those grants during the six months ended June 30, 2014. No options granted during the six months ended June 30, 2015 were valued using the Monte Carlo option valuation model. Risk-Free Derived Grant Number Exercise Grant Date Interest Estimated Dividend Expected Period Date of Shares Price Fair Value Rate Volatility Yield Life (years) (years) January 14 - Tranche 1 10,000 $ 31.125 $ 5.64 1.98 % 31 % 4.50 % 5.15 0.31 January 14 - Tranche 2 10,000 $ 31.125 $ 5.46 1.98 % 31 % 4.50 % 5.58 1.15 January 14 - Tranche 3 10,000 $ 31.125 $ 5.03 1.98 % 31 % 4.50 % 5.97 1.94 January 14 - Tranche 4 10,000 $ 31.125 $ 4.27 1.98 % 31 % 4.50 % 6.25 2.50 February 14 - Tranche 1 25,000 $ 30.88 $ 5.51 1.98 % 31 % 4.60 % 5.17 0.35 February 14 - Tranche 2 25,000 $ 30.88 $ 5.35 1.98 % 31 % 4.60 % 5.60 1.19 February 14 - Tranche 3 25,000 $ 30.88 $ 4.88 1.98 % 31 % 4.60 % 5.99 1.98 February 14 - Tranche 4 25,000 $ 30.88 $ 4.15 1.98 % 31 % 4.60 % 6.27 2.54 May 14 - Tranche 1 1,250 $ 28.185 $ 5.06 2.03 % 31 % 4.70 % 5.36 0.71 May 14 - Tranche 2 1,250 $ 28.185 $ 4.74 2.03 % 31 % 4.70 % 5.78 1.56 May 14 - Tranche 3 1,250 $ 28.185 $ 4.02 2.03 % 31 % 4.70 % 6.14 2.29 May 14 - Tranche 4 1,250 $ 28.185 $ 3.29 2.03 % 31 % 4.70 % 6.39 2.79 The Company expenses the cost of these options granted over the implicit, or derived, service period of the option based on the grant-date fair value of the award. Options Issued Outside of the 2014 Plan In April 2014, the Company’s stockholders voted to approve the options granted to Mr. Jeffrey S. Schoen, the Company’s President and Chief Executive Officer, on November 8, 2013. Upon his appointment as an officer of the Company, Mr. Schoen was granted an option to purchase up to 400,000 shares of the common stock of the Company at a purchase price of $30.25 per share. The option will become exercisable, if at all, if and when the share price of the Company’s common stock closes at a certain percentage of the purchase price of the option for three consecutive business days, in accordance with the following vesting schedule: Share price closes at or above the following percentage of the purchase price for the Option Number of shares that become vested 115% (share price $34.788) 100,000 140% (share price $42.35) 100,000 170% (share price $51.425) 100,000 200% (share price $60.50) 100,000 These options were granted outside of the 2005 Plan or the 2014 Plan. Any unvested portion of the option shall expire five years from the date of grant and the option shall terminate ten years after the date of grant. The Company used a Monte Carlo option valuation model to estimate the grant date fair value of each tranche of 100,000 options, as they include a market condition. The Company will expense the cost of the options granted over the implicit service period of the options based on the completed Monte Carlo models. The following table details the assumptions used in the valuation model for the options granted to Mr. Schoen: Risk-Free Derived Number Exercise Grant Date Interest Estimated Dividend Expected Period of Shares Price Fair Value Rate Volatility Yield Life (years) (years) Tranche 1 100,000 $ 30.25 $ 5.18 2.10 % 30 % 4.60 % 4.99 0.40 Tranche 2 100,000 $ 30.25 $ 5.04 2.10 % 30 % 4.60 % 5.42 1.25 Tranche 3 100,000 $ 30.25 $ 4.31 2.10 % 30 % 4.60 % 5.79 2.00 Tranche 4 100,000 $ 30.25 $ 3.50 2.10 % 30 % 4.60 % 6.04 2.50 Total Option Expense The Company recognized the following expenses related to all options granted under the 2005 Plan, the 2014 Plan and the Schoen options: Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Time-Based Vesting Options $ 186,000 $ 302,000 $ 187,000 $ 306,000 Market-Based Vesting Options 224,000 690,000 478,000 837,000 Total compensation expense related to stock options $ 410,000 $ 992,000 $ 665,000 $ 1,143,000 Future Expected Market-Based Stock Option Expense The grant of options that vest based on a market condition will have a material impact on the Company’s results of operations. Based on the derived service periods of the options, the Company expects to expense the compensation cost related to these options as shown in the following table. However, if the market condition is achieved for any tranche of these options prior to the end of the derived service period, all remaining expense related to that tranche would be recognized in the period in which the market condition is achieved. 2015 2015 2016 Q1 Q2 Q3 Q4 Total Total (in thousands) Tranche 1 $ - $ - $ - $ - $ - $ - Tranche 2 134 104 1 1 240 - Tranche 3 73 72 72 72 289 59 Tranche 4 47 48 47 47 189 136 Total expense $ 254 $ 224 $ 120 $ 120 $ 718 $ 195 Restricted Stock In February 2013, the Company granted 16,000 shares of restricted stock to certain employees under the 2005 Plan. These awards were valued at the arithmetic mean of the high and low market price of the Company’s stock on the grant date, which was $21.695 per share, and vest ratably over a three year period beginning on the first anniversary of the grant date. The first third of unforfeited shares, or 2,666 shares, vested in February 2014. The second third of unforfeited shares, or 2,333 shares, vested in February 2015. The Company expenses the cost of restricted stock granted over the vesting period of the shares based on the grant-date fair value of the award. The Company recognized expense of $12,000 and $14,000 for the three-month periods ended June 30, 2015 and 2014, respectively, and $25,000 and $29,000 for the six-month periods ended June 30, 2015 and 2014, respectively, related to shares of restricted stock granted. |